Latest / The News Front Podcast
Regenerative Medical Solutions Secures NIH Grant to Revolutionize Diabetes Treatment
MADISON, WISCONSIN – Regenerative Medical Solutions (RMS), a Wisconsin-based biotech company, has been awarded a peer-reviewed National Institutes of Health (NIH) Phase II Small Business Innovation Research (SBIR) grant of approximately $1.8 million to advance its prospective cure for diabetes to the next stage of trials.RMS is inviting visionary investors to join its mission of delivering a groundbreaking cure for diabetes to millions in need. This transformative initiative has the power to change lives while offering an exceptional opportunity for significant returns and market…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.